Dichotomous roles of RIPK3 in regulating the IFN response and NLRP3 inflammasome in human monocytes.

Overview

Regulation of the profile and magnitude of TLR responses is important for effective host defense against infections while minimizing inflammatory toxicity. The chemokine CXCL4 regulates the TLR8 response to amplify inflammatory gene and inflammasome activation while attenuating the IFN response in primary monocytes. In this study, we describe an unexpected role for the kinase RIPK3 in suppressing the (CXCL4 + TLR8)-induced IFN response and providing 'signal 2' to activate the NLRP3 inflammasome and IL-1 production in primary human monocytes. RIPK3 also amplifies induction of inflammatory genes such as TNF, IL6 and IL1B while suppressing IL12B. Mechanistically, RIPK3 inhibits STAT1 activation and activates PI3K-Akt-dependent and XBP1- and NRF2-mediated stress responses to regulate downstream genes in a dichotomous manner. These findings identify new functions for RIPK3 in modulating TLR responses and provide potential mechanisms by which RIPK3 plays roles in inflammatory diseases, and suggest targeting RIPK3 and XBP1- and NRF2-mediated stress responses as therapeutic strategies to suppress inflammation while preserving the IFN response for host defense.